Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Towards new mechanisms: an update on therapeutics for treatment-resistant major depressive disorder
Authors
Keywords
-
Journal
MOLECULAR PSYCHIATRY
Volume 20, Issue 10, Pages 1142-1150
Publisher
Springer Nature
Online
2015-07-07
DOI
10.1038/mp.2015.92
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nitrous Oxide for Treatment-Resistant Major Depression: A Proof-of-Concept Trial
- (2015) Peter Nagele et al. BIOLOGICAL PSYCHIATRY
- The Nature of Placebo Response in Clinical Studies of Major Depressive Disorder
- (2015) George I. Papakostas et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study of the Augmentation of a Nicotinic Acetylcholine Receptor Partial Agonist in Depression
- (2015) Maurizio Fava et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Vortioxetine, a novel antidepressant with multimodal activity: Review of preclinical and clinical data
- (2015) Connie Sanchez et al. PHARMACOLOGY & THERAPEUTICS
- Efficacy and safety of deep transcranial magnetic stimulation for major depression: a prospective multicenter randomized controlled trial
- (2015) Yechiel Levkovitz et al. World Psychiatry
- Vortioxetine for the Treatment of Depression
- (2014) Erica F. Pearce et al. ANNALS OF PHARMACOTHERAPY
- A Randomized Controlled Trial of Intranasal Ketamine in Major Depressive Disorder
- (2014) Kyle A.B. Lapidus et al. BIOLOGICAL PSYCHIATRY
- A single infusion of ketamine improves depression scores in patients with anxious bipolar depression
- (2014) Dawn F Ionescu et al. BIPOLAR DISORDERS
- The Efficacy and Safety of Low Frequency Repetitive Transcranial Magnetic Stimulation for Treatment-resistant Depression: The Results From a Large Multicenter French RCT
- (2014) Jerome Brunelin et al. Brain Stimulation
- P.2.f.027 The efficacy and safety of basimglurant as adjunctive therapy in major depression; a randomised, double-blind, placebo-controlled study
- (2014) J.A. Quiroz et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- Celecoxib: a new augmentation strategy for depressive mood episodes. A systematic review and meta-analysis of randomized placebo-controlled trials
- (2014) Farhad Faridhosseini et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A randomised, double-blind study in adults with major depressive disorder with an inadequate response to a single course of selective serotonin reuptake inhibitor or serotonin-noradrenaline reuptake inhibitor treatment switched to vortioxetine or agomelat
- (2014) Stuart A. Montgomery et al. HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
- A double-blind, placebo-controlled study of edivoxetine as an adjunctive treatment for patients with major depressive disorder who are partial responders to selective serotonin reuptake inhibitor treatment
- (2014) Susan Ball et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressant treatment history as a predictor of response to scopolamine: clinical implications
- (2014) Jessica S. Ellis et al. JOURNAL OF AFFECTIVE DISORDERS
- Effect of Adjunctivel-Methylfolate 15 mg Among Inadequate Responders to SSRIs in Depressed Patients Who Were Stratified by Biomarker Levels and Genotype
- (2014) George I. Papakostas et al. JOURNAL OF CLINICAL PSYCHIATRY
- Updates and Trends in the Treatment of Major Depressive Disorder
- (2014) George I. Papakostas et al. JOURNAL OF CLINICAL PSYCHIATRY
- Effect of Baseline Anxious Depression on Initial and Sustained Antidepressant Response to Ketamine
- (2014) Dawn F. Ionescu et al. JOURNAL OF CLINICAL PSYCHIATRY
- An Overview of Vortioxetine
- (2014) Alan F. Schatzberg et al. JOURNAL OF CLINICAL PSYCHIATRY
- Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Depression
- (2014) Bradley N. Gaynes et al. JOURNAL OF CLINICAL PSYCHIATRY
- Riluzole likely lacks antidepressant efficacy in ketamine non-responders
- (2014) Mark J. Niciu et al. JOURNAL OF PSYCHIATRIC RESEARCH
- Evaluation of Opioid Modulation in Major Depressive Disorder
- (2014) Elliot Ehrich et al. NEUROPSYCHOPHARMACOLOGY
- Inflamed moods: A review of the interactions between inflammation and mood disorders
- (2014) Joshua D. Rosenblat et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- A Review of the Clinical, Economic, and Societal Burden of Treatment-Resistant Depression: 1996–2013
- (2014) David A. Mrazek et al. PSYCHIATRIC SERVICES
- A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes
- (2014) A. McGirr et al. PSYCHOLOGICAL MEDICINE
- Effect of Anti-inflammatory Treatment on Depression, Depressive Symptoms, and Adverse Effects
- (2014) Ole Köhler et al. JAMA Psychiatry
- Anti-anhedonic effect of ketamine and its neural correlates in treatment-resistant bipolar depression
- (2014) N Lally et al. Translational Psychiatry
- Antidepressant Efficacy of Ketamine in Treatment-Resistant Major Depression: A Two-Site Randomized Controlled Trial
- (2013) James W. Murrough et al. AMERICAN JOURNAL OF PSYCHIATRY
- Rapid Mood-Elevating Effects of Low Field Magnetic Stimulation in Depression
- (2013) Michael L. Rohan et al. BIOLOGICAL PSYCHIATRY
- Scopolamine as an Antidepressant
- (2013) Robert J. Jaffe et al. CLINICAL NEUROPHARMACOLOGY
- Efficacy and tolerability of flexibly-dosed adjunct TC-5214 (dexmecamylamine) in patients with major depressive disorder and inadequate response to prior antidepressant
- (2013) Eduard Vieta et al. EUROPEAN NEUROPSYCHOPHARMACOLOGY
- GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists
- (2013) Joseph R Moskal et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Combining a dopamine agonist and selective serotonin reuptake inhibitor for the treatment of depression: A double-blind, randomized pilot study
- (2013) Jose A. Franco-Chaves et al. JOURNAL OF AFFECTIVE DISORDERS
- Aripiprazole augmentation to antidepressant therapy in Japanese patients with major depressive disorder: A randomized, double-blind, placebo-controlled study (ADMIRE study)
- (2013) Kunitoshi Kamijima et al. JOURNAL OF AFFECTIVE DISORDERS
- Antidepressant Augmentation Using theN-Methyl-d-Aspartate Antagonist Memantine
- (2013) Eric G. Smith et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized Controlled Trial of the Efficacy and Safety of Lisdexamfetamine Dimesylate as Augmentation Therapy in Adults With Residual Symptoms of Major Depressive Disorder After Treatment With Escitalopram
- (2013) Madhukar H. Trivedi et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Double-Blind, Placebo-Controlled Trial of Pramipexole Augmentation in Treatment-Resistant Major Depressive Disorder
- (2013) Cristina Cusin et al. JOURNAL OF CLINICAL PSYCHIATRY
- Cognitive Symptoms in Patients With Major Depressive Disorder and Their Implications for Clinical Practice
- (2013) George I. Papakostas JOURNAL OF CLINICAL PSYCHIATRY
- Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010
- (2013) Harvey A Whiteford et al. LANCET
- Ketamine: synaptogenesis, immunomodulation and glycogen synthase kinase-3 as underlying mechanisms of its antidepressant properties
- (2013) P A Zunszain et al. MOLECULAR PSYCHIATRY
- Lanicemine: a low-trapping NMDA channel blocker produces sustained antidepressant efficacy with minimal psychotomimetic adverse effects
- (2013) G Sanacora et al. MOLECULAR PSYCHIATRY
- LY2456302 is a novel, potent, orally-bioavailable small molecule kappa-selective antagonist with activity in animal models predictive of efficacy in mood and addictive disorders
- (2013) Linda M. Rorick-Kehn et al. NEUROPHARMACOLOGY
- GLYX-13, a NMDA Receptor Glycine-Site Functional Partial Agonist, Induces Antidepressant-Like Effects Without Ketamine-Like Side Effects
- (2013) Jeffrey Burgdorf et al. NEUROPSYCHOPHARMACOLOGY
- Recombinant Human Erythropoietin for Treating Treatment-Resistant Depression: A Double-Blind, Randomized, Placebo-Controlled Phase 2 Trial
- (2013) Kamilla W Miskowiak et al. NEUROPSYCHOPHARMACOLOGY
- Efficacy of adjunctive celecoxib treatment for patients with major depressive disorder: A meta-analysis
- (2013) Kyoung-Sae Na et al. PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY
- Maximum Tolerated Dose Evaluation of the AMPA Modulator Org 26576 in Healthy Volunteers and Depressed Patients
- (2013) Kari R. Nations et al. Drugs in research & development
- l-Methylfolate as Adjunctive Therapy for SSRI-Resistant Major Depression: Results of Two Randomized, Double-Blind, Parallel-Sequential Trials
- (2012) George I. Papakostas et al. AMERICAN JOURNAL OF PSYCHIATRY
- A Randomized Trial of a Low-Trapping Nonselective N-Methyl-D-Aspartate Channel Blocker in Major Depression
- (2012) Carlos A. Zarate et al. BIOLOGICAL PSYCHIATRY
- Deep transcranial magnetic stimulation as a treatment for psychiatric disorders: A comprehensive review
- (2012) F.S. Bersani et al. EUROPEAN PSYCHIATRY
- Does the Presence of an Open-Label Antidepressant Treatment Period Influence Study Outcome in Clinical Trials Examining Augmentation/Combination Strategies in Treatment Partial Responders/Nonresponders With Major Depressive Disorder?
- (2012) Nadia Iovieno et al. JOURNAL OF CLINICAL PSYCHIATRY
- Correlation Between Different Levels of Placebo Response Rate and Clinical Trial Outcome in Major Depressive Disorder
- (2012) Nadia Iovieno et al. JOURNAL OF CLINICAL PSYCHIATRY
- A Randomized, Placebo-Controlled, Crossover Pilot Trial of the Oral Selective NR2B Antagonist MK-0657 in Patients With Treatment-Resistant Major Depressive Disorder
- (2012) Lobna Ibrahim et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial
- (2012) Kari R Nations et al. JOURNAL OF PSYCHOPHARMACOLOGY
- An extension of hypotheses regarding rapid-acting, treatment-refractory, and conventional antidepressant activity of dextromethorphan and dextrorphan
- (2012) Edward C. Lauterbach MEDICAL HYPOTHESES
- Course of Improvement in Depressive Symptoms to a Single Intravenous Infusion of Ketamine vs Add-on Riluzole: Results from a 4-Week, Double-Blind, Placebo-Controlled Study
- (2012) Lobna Ibrahim et al. NEUROPSYCHOPHARMACOLOGY
- H-coil repetitive transcranial magnetic stimulation for treatment resistant major depressive disorder: An 18-week continuation safety and feasibility study
- (2012) Eiran Vadim Harel et al. WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY
- A Randomized Controlled Trial of the Tumor Necrosis Factor Antagonist Infliximab for Treatment-Resistant Depression
- (2012) Charles L. Raison et al. JAMA Psychiatry
- α4β2 nicotinic acetylcholine receptor partial agonists with low intrinsic efficacy have antidepressant-like properties
- (2011) Yann S. Mineur et al. BEHAVIOURAL PHARMACOLOGY
- Exercise as an Augmentation Treatment for Nonremitted Major Depressive Disorder
- (2011) Madhukar H. Trivedi et al. JOURNAL OF CLINICAL PSYCHIATRY
- Transcranial Magnetic Stimulation in the Management of Mood Disorders
- (2011) Charlotte L. Allan et al. NEUROPSYCHOBIOLOGY
- (S)-(+)-Mecamylamine (TC-5214): A Neuronal Nicotinic Receptor Modulator Enters Phase III Trials as an Adjunct Treatment for Major Depressive Disorder (MDD)
- (2010) Craig W. Lindsley ACS Chemical Neuroscience
- S-Adenosyl Methionine (SAMe) Augmentation of Serotonin Reuptake Inhibitors for Antidepressant Nonresponders With Major Depressive Disorder: A Double-Blind, Randomized Clinical Trial
- (2010) George I. Papakostas et al. AMERICAN JOURNAL OF PSYCHIATRY
- Association of Mu-Opioid Receptor Variants and Response to Citalopram Treatment in Major Depressive Disorder
- (2010) Holly A. Garriock et al. AMERICAN JOURNAL OF PSYCHIATRY
- Replication of Scopolamine's Antidepressant Efficacy in Major Depressive Disorder: A Randomized, Placebo-Controlled Clinical Trial
- (2010) Wayne C. Drevets et al. BIOLOGICAL PSYCHIATRY
- Rapid Resolution of Suicidal Ideation After a Single Infusion of anN-Methyl-D-Aspartate Antagonist in Patients With Treatment-Resistant Major Depressive Disorder
- (2010) Nancy DiazGranados et al. JOURNAL OF CLINICAL PSYCHIATRY
- Parallel-Group Placebo-Controlled Trial of Testosterone Gel in Men With Major Depressive Disorder Displaying an Incomplete Response to Standard Antidepressant Treatment
- (2010) Harrison G. Pope et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Scopolamine Produces Larger Antidepressant and Antianxiety Effects in Women Than in Men
- (2010) Maura L Furey et al. NEUROPSYCHOPHARMACOLOGY
- Atypical Antipsychotic Augmentation in Major Depressive Disorder: A Meta-Analysis of Placebo-Controlled Randomized Trials
- (2009) J. Craig Nelson et al. AMERICAN JOURNAL OF PSYCHIATRY
- Effects of Intravenous Ketamine on Explicit and Implicit Measures of Suicidality in Treatment-Resistant Depression
- (2009) Rebecca B. Price et al. BIOLOGICAL PSYCHIATRY
- Opiates as Antidepressants
- (2009) Esther Berrocoso et al. CURRENT PHARMACEUTICAL DESIGN
- Managing Partial Response or Nonresponse
- (2009) George I. Papakostas JOURNAL OF CLINICAL PSYCHIATRY
- Antidepressant-Like Effects of κ-Opioid Receptor Antagonists in Wistar Kyoto Rats
- (2009) Gregory V Carr et al. NEUROPSYCHOPHARMACOLOGY
- The Role of AMPA receptor modulation in the treatment of neuropsychiatric diseases
- (2008) Carlos A. Zarate et al. EXPERIMENTAL NEUROLOGY
- Therapeutic potential of erythropoietin and its structural or functional variants in the nervous system
- (2008) Anna-Leena Sirén et al. Neurotherapeutics
- Mood disorders: Regulation by metabotropic glutamate receptors
- (2007) Andrzej Pilc et al. BIOCHEMICAL PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now